Amplia Therapeutics (INNMF) Stock Price, Quote, News & History

Q: What sector and industry does Amplia Therapeutics (INNMF) operate in?

Amplia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.

Comments

Amplia Therapeutics Ltd (INNMF) Stock Price, Quote, News & History

INNMFOTCQB

Logo brought to you by Benzinga Data

Trade with Public

$0.0980

0.01822.50%

At close: Feb 6, 4:00 PM EST

Overview

News Short Interest

Key Statistics

Open

$0.10

Volume / Avg.

6.12K / 30.07K

Day Range

$0.10 - $0.10

52 Wk Range

0.03 - 0.27

Market Cap

$50.28M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Amplia Therapeutics Ltd News

Stocks That Hit 52-Week Lows On Thursday

Lisa Levin

Stocks That Hit 52-Week Lows On Tuesday

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

-81.65K

Financing Cash Flow (TTM)

37.99M

Free Cash Flow (TTM)

-13.39M

Capital Expenditure (TTM)

-27.69K

Net Change in Cash (TTM)

24.55M

Valuation Metrics

Enterprise Value

$22.93M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

1.36

Earnings Yield % (TTM)

-17.84%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.06

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$10.86M

Debt to Equity

0.00

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.10

Volume / Avg.

6.12K / 30.07K

Day Range

$0.10 - $0.10

52 Wk Range

0.03 - 0.27

Market Cap

$50.28M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-actio...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Amplia Therapeutics (INNMF) stock?

You can purchase shares of Amplia Therapeutics (OTCQB:INNMF) through any online brokerage.

View our list of the best stock brokerages

Who are Amplia Therapeutics (INNMF) competitors?

There are no as such competitors for Amplia Therapeutics.

What is the forecast, or price target, for Amplia Therapeutics (INNMF) stock?

There is no analysis for Amplia Therapeutics to provide a consensus price target.

What is the current price for Amplia Therapeutics (INNMF)?

The stock price for Amplia Therapeutics (OTCQB: INNMF) is $0.098 last updated February 6, 2026 at 1:31 PM EST.

Does Amplia Therapeutics (INNMF) pay a dividend?

There are no upcoming dividends for Amplia Therapeutics.

When is Amplia Therapeutics (OTCQB:INNMF) reporting earnings?

Amplia Therapeutics does not have any upcoming earnings scheduled.

Is Amplia Therapeutics (INNMF) going to split?

There is no upcoming split for Amplia Therapeutics.

What sector and industry does Amplia Therapeutics (INNMF) operate in?

Amplia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.

Key Statistics

Open

$0.10

Volume / Avg.

6.12K / 30.07K

Day Range

$0.10 - $0.10

52 Wk Range

0.03 - 0.27

Market Cap

$50.28M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Amplia Therapeutics Ltd News

Stocks That Hit 52-Week Lows On Thursday

Lisa Levin

Stocks That Hit 52-Week Lows On Tuesday

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

-81.65K

Financing Cash Flow (TTM)

37.99M

Free Cash Flow (TTM)

-13.39M

Capital Expenditure (TTM)

-27.69K

Net Change in Cash (TTM)

24.55M

Valuation Metrics

Enterprise Value

$22.93M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

1.36

Earnings Yield % (TTM)

-17.84%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.06

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$10.86M

Debt to Equity

0.00

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.10

Volume / Avg.

6.12K / 30.07K

Day Range

$0.10 - $0.10

52 Wk Range

0.03 - 0.27

Market Cap

$50.28M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Amplia Therapeutics (INNMF) stock?

You can purchase shares of Amplia Therapeutics (OTCQB:INNMF) through any online brokerage.

View our list of the best stock brokerages

Who are Amplia Therapeutics (INNMF) competitors?

There are no as such competitors for Amplia Therapeutics.

What is the forecast, or price target, for Amplia Therapeutics (INNMF) stock?

There is no analysis for Amplia Therapeutics to provide a consensus price target.

What is the current price for Amplia Therapeutics (INNMF)?

The stock price for Amplia Therapeutics (OTCQB: INNMF) is $0.098 last updated February 6, 2026 at 1:31 PM EST.

Does Amplia Therapeutics (INNMF) pay a dividend?

There are no upcoming dividends for Amplia Therapeutics.

When is Amplia Therapeutics (OTCQB:INNMF) reporting earnings?

Amplia Therapeutics does not have any upcoming earnings scheduled.

Is Amplia Therapeutics (INNMF) going to split?

There is no upcoming split for Amplia Therapeutics.

What sector and industry does Amplia Therapeutics (INNMF) operate in?

Amplia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.